[go: up one dir, main page]

SI3566712T1 - Sestavek za nadzorovano stimulacijo jajčnikov - Google Patents

Sestavek za nadzorovano stimulacijo jajčnikov

Info

Publication number
SI3566712T1
SI3566712T1 SI201231884T SI201231884T SI3566712T1 SI 3566712 T1 SI3566712 T1 SI 3566712T1 SI 201231884 T SI201231884 T SI 201231884T SI 201231884 T SI201231884 T SI 201231884T SI 3566712 T1 SI3566712 T1 SI 3566712T1
Authority
SI
Slovenia
Prior art keywords
composition
ovarian stimulation
controlled ovarian
controlled
stimulation
Prior art date
Application number
SI201231884T
Other languages
English (en)
Inventor
Joan-Carles Arce
Original Assignee
Ferring B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46785372&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI3566712(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring B.V. filed Critical Ferring B.V.
Publication of SI3566712T1 publication Critical patent/SI3566712T1/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/24Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SI201231884T 2011-08-08 2012-08-08 Sestavek za nadzorovano stimulacijo jajčnikov SI3566712T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11176803 2011-08-08
EP19164277.6A EP3566712B1 (en) 2011-08-08 2012-08-08 Composition for controlled ovarian stimulation

Publications (1)

Publication Number Publication Date
SI3566712T1 true SI3566712T1 (sl) 2021-04-30

Family

ID=46785372

Family Applications (8)

Application Number Title Priority Date Filing Date
SI201231921T SI3646881T1 (sl) 2011-08-08 2012-08-08 Sestavek za nadzorovano stimulacijo jajčnikov
SI201231653T SI3395357T1 (sl) 2011-08-08 2012-08-08 Sestavek za nadzorovano stimulacijo jajčnikov
SI201230438T SI2741763T1 (sl) 2011-08-08 2012-08-08 Sestavek za nadzorovano stimulacijo ovarija
SI201231493T SI2821080T1 (sl) 2011-08-08 2012-08-08 Sestavek za nadzorovano stimulacijo jajčnikov
SI201232033T SI3756681T1 (sl) 2011-08-08 2012-08-08 Sestavek za nadzorovano stimulacijo jajčnikov
SI201231884T SI3566712T1 (sl) 2011-08-08 2012-08-08 Sestavek za nadzorovano stimulacijo jajčnikov
SI201231398T SI3195875T1 (sl) 2011-08-08 2012-08-08 Sestavek za nadzorovano stimulacijo jajčnikov
SI201232063T SI4005588T1 (sl) 2011-08-08 2012-08-08 Sestavek za nadzorovano stimulacijo jajčnikov

Family Applications Before (5)

Application Number Title Priority Date Filing Date
SI201231921T SI3646881T1 (sl) 2011-08-08 2012-08-08 Sestavek za nadzorovano stimulacijo jajčnikov
SI201231653T SI3395357T1 (sl) 2011-08-08 2012-08-08 Sestavek za nadzorovano stimulacijo jajčnikov
SI201230438T SI2741763T1 (sl) 2011-08-08 2012-08-08 Sestavek za nadzorovano stimulacijo ovarija
SI201231493T SI2821080T1 (sl) 2011-08-08 2012-08-08 Sestavek za nadzorovano stimulacijo jajčnikov
SI201232033T SI3756681T1 (sl) 2011-08-08 2012-08-08 Sestavek za nadzorovano stimulacijo jajčnikov

Family Applications After (2)

Application Number Title Priority Date Filing Date
SI201231398T SI3195875T1 (sl) 2011-08-08 2012-08-08 Sestavek za nadzorovano stimulacijo jajčnikov
SI201232063T SI4005588T1 (sl) 2011-08-08 2012-08-08 Sestavek za nadzorovano stimulacijo jajčnikov

Country Status (30)

Country Link
US (5) US9694052B2 (sl)
EP (9) EP4005588B1 (sl)
JP (5) JP6161609B2 (sl)
KR (8) KR20250126867A (sl)
CN (2) CN107281470A (sl)
AR (1) AR087476A1 (sl)
AU (3) AU2012293647B2 (sl)
BR (2) BR122020001644B1 (sl)
CA (1) CA2844282A1 (sl)
CY (1) CY1117214T1 (sl)
DK (8) DK3566712T3 (sl)
ES (8) ES2884947T3 (sl)
FI (2) FI3756681T3 (sl)
HR (8) HRP20160145T1 (sl)
HU (8) HUE027674T2 (sl)
IL (2) IL300380A (sl)
JO (1) JO3092B1 (sl)
LT (7) LT3646881T (sl)
MX (5) MX348981B (sl)
PL (8) PL3395357T3 (sl)
PT (6) PT2821080T (sl)
RS (8) RS64328B1 (sl)
RU (2) RU2613324C3 (sl)
SA (1) SA112330762B1 (sl)
SI (8) SI3646881T1 (sl)
SM (1) SMT201600038B (sl)
TR (2) TR201900071T4 (sl)
TW (2) TWI657822B (sl)
WO (1) WO2013020996A1 (sl)
ZA (2) ZA201400952B (sl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI488640B (zh) 2008-04-16 2015-06-21 Ferring Int Ct Sa 藥學製劑
TWI532495B (zh) * 2009-10-05 2016-05-11 菲瑞茵國際中心股份有限公司 藥學製劑
JO3092B1 (ar) 2011-08-08 2017-03-15 Ferring Bv مركب لتحفيز مسيطر عليه للمبيض
WO2016102436A1 (en) * 2014-12-22 2016-06-30 F. Hoffmann-La Roche Ag Cmp-dependent sialidase activity
HUE048757T2 (hu) * 2015-04-17 2020-08-28 Ferring Bv FSH meddõség kezelésére
AU2016282916B2 (en) 2015-06-26 2022-01-20 Ferring B.V. Methods of purification and/or viral inactivation
BR112018003455A2 (pt) * 2015-09-17 2018-09-25 Glycotope Gmbh composição ou composição farmacêutica e uso da composição
TWI778979B (zh) * 2016-09-30 2022-10-01 瑞士商麥歐文科學有限公司 治療女性不孕症之方法
MA50034B1 (fr) * 2017-09-01 2022-02-28 Ferring Bv Composition de stimulation ovarienne contrôlée
PL3787667T3 (pl) 2018-04-30 2025-07-28 Ferring B.V. Kompozycja do kontrolowanej stymulacji jajników
TWI846743B (zh) 2018-10-17 2024-07-01 荷蘭商菲林公司 用於控制性卵巢刺激之組成物及方法
US11576920B2 (en) 2019-03-18 2023-02-14 The Menopause Method, Inc. Composition and method to aid in hormone replacement therapy
CN110841060A (zh) * 2019-11-21 2020-02-28 上海交通大学 Choriogonadotropin alfa在治疗多囊卵巢综合征中的应用
TW202237173A (zh) 2020-12-09 2022-10-01 荷蘭商菲林公司 用於受控的卵巢刺激之組成物及方法
AU2022451605A1 (en) 2022-04-01 2024-09-26 Ferring B.V. Mixed protocol for treatment of infertility
KR20250016113A (ko) 2022-05-26 2025-02-03 훼링 비.브이. 남성 불임 치료를 위한 조성물 및 방법
MA71382A (fr) 2022-07-08 2025-04-30 Ferring B.V. Compositions et procédés d'insémination intra-utérine (iiu)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW518235B (en) 1997-01-15 2003-01-21 Akzo Nobel Nv A gonadotropin-containing pharmaceutical composition with improved stability on prolong storage
EP1074265A1 (en) * 1999-08-03 2001-02-07 Erasmus Universiteit Rotterdam Use of AMH and/or AMH agonists and/or AMH antagonists for long-term control of female fertility
IL161235A0 (en) * 2001-10-22 2004-09-27 Applied Research Systems Fsh composition, its preparation and use
US20040248784A1 (en) * 2003-06-03 2004-12-09 Marco Filicori Unitary combinations of FSH and hCG
US8501719B2 (en) * 2005-11-08 2013-08-06 American Infertility Of New York Androgen treatment in females
TWI488640B (zh) * 2008-04-16 2015-06-21 Ferring Int Ct Sa 藥學製劑
TWI532495B (zh) * 2009-10-05 2016-05-11 菲瑞茵國際中心股份有限公司 藥學製劑
DE102010007984B4 (de) 2010-02-15 2012-01-26 Hochland Ag Form- und Kühlvorrichtung für eine fließfähige, aufgeschmolzene Lebensmittelmasse
EP2417982A1 (en) 2010-07-30 2012-02-15 Ferring B.V. Stabilization of gonadotropins
WO2012016576A1 (en) 2010-08-04 2012-02-09 Glycotope Gmbh Improved recombinant human follicle-stimulating hormone
RS54214B2 (sr) * 2010-09-29 2024-02-29 Ferring Bv Smeša za upotrebu u lečenju infertiliteta
JO3092B1 (ar) 2011-08-08 2017-03-15 Ferring Bv مركب لتحفيز مسيطر عليه للمبيض

Also Published As

Publication number Publication date
MX2024008826A (es) 2024-07-25
BR112014002884A2 (pt) 2017-02-21
WO2013020996A1 (en) 2013-02-14
LT3395357T (lt) 2019-08-26
RU2014102924A (ru) 2015-09-20
KR102499969B1 (ko) 2023-02-14
RS57897B1 (sr) 2019-01-31
MX2014001489A (es) 2014-04-25
KR102111514B1 (ko) 2020-05-18
DK3756681T5 (da) 2024-08-26
LT2821080T (lt) 2019-01-10
HUE062640T2 (hu) 2023-11-28
KR20250126867A (ko) 2025-08-25
LT3195875T (lt) 2018-11-12
JP6161609B2 (ja) 2017-07-12
ZA201506382B (en) 2017-01-25
JP2017141253A (ja) 2017-08-17
PT2821080T (pt) 2018-12-17
CA2844282A1 (en) 2013-02-14
RS61672B1 (sr) 2021-04-29
PL3756681T3 (pl) 2023-08-21
IL230696B2 (en) 2023-07-01
DK2821080T3 (en) 2019-01-28
HUE041769T2 (hu) 2019-05-28
EP3395357A1 (en) 2018-10-31
EP3756681B1 (en) 2023-05-03
EP4306174A2 (en) 2024-01-17
EP2821080A1 (en) 2015-01-07
AU2016273925A1 (en) 2017-01-12
LT3566712T (lt) 2021-03-10
PL4005588T3 (pl) 2024-06-10
SMT201600038B (it) 2016-02-25
SI4005588T1 (sl) 2024-06-28
PL3195875T3 (pl) 2019-01-31
AR087476A1 (es) 2014-03-26
HRP20230607T1 (hr) 2023-09-29
US20250302923A1 (en) 2025-10-02
RU2613324C2 (ru) 2017-03-15
KR20190140098A (ko) 2019-12-18
HUE040058T2 (hu) 2019-02-28
SI3646881T1 (sl) 2021-08-31
EP3566712A1 (en) 2019-11-13
AU2012293647B2 (en) 2016-10-06
PL2741763T3 (pl) 2016-07-29
IL230696A0 (en) 2014-03-31
EP3195875B1 (en) 2018-07-25
HRP20160145T1 (hr) 2016-04-08
LT3646881T (lt) 2021-05-25
EP4005588B1 (en) 2024-02-07
DK4005588T3 (da) 2024-04-29
DK3195875T3 (en) 2018-11-12
RS64328B1 (sr) 2023-08-31
HRP20210722T1 (hr) 2021-06-11
LT3756681T (lt) 2023-07-25
EP3566712B1 (en) 2021-01-27
DK3756681T3 (da) 2023-07-31
RU2613324C3 (ru) 2021-06-09
RS58198B1 (sr) 2019-03-29
HK1204923A1 (en) 2015-12-11
EP3756681A1 (en) 2020-12-30
SI3395357T1 (sl) 2019-09-30
US9694052B2 (en) 2017-07-04
CN107281470A (zh) 2017-10-24
KR102353144B1 (ko) 2022-01-18
HRP20210277T1 (hr) 2021-04-02
ES2692774T3 (es) 2018-12-05
US12478660B2 (en) 2025-11-25
HUE044610T2 (hu) 2019-11-28
HUE066158T2 (hu) 2024-07-28
RS65485B1 (sr) 2024-05-31
PL3566712T3 (pl) 2021-07-12
EP3195875A1 (en) 2017-07-26
ES2871405T3 (es) 2021-10-28
HUE053716T2 (hu) 2021-07-28
PL2821080T3 (pl) 2019-04-30
ES2704878T3 (es) 2019-03-20
JP2020147600A (ja) 2020-09-17
HUE054312T2 (hu) 2021-08-30
PL3646881T3 (pl) 2021-11-02
PT3756681T (pt) 2023-07-25
KR20200121918A (ko) 2020-10-26
SA112330762B1 (ar) 2015-10-08
RU2017106756A3 (sl) 2020-07-09
PT3195875T (pt) 2018-10-31
PL3395357T3 (pl) 2019-11-29
EP2741763A1 (en) 2014-06-18
EP2821080B1 (en) 2018-10-10
TR201911269T4 (tr) 2019-08-21
TW201309322A (zh) 2013-03-01
US20200345814A1 (en) 2020-11-05
KR20210099162A (ko) 2021-08-11
JP2023134561A (ja) 2023-09-27
HK1198005A1 (zh) 2015-03-06
ZA201400952B (en) 2022-03-30
KR20140054191A (ko) 2014-05-08
SI3756681T1 (sl) 2023-08-31
PT3646881T (pt) 2021-06-02
EP4005588A1 (en) 2022-06-01
PT3395357T (pt) 2019-08-27
CN103732243A (zh) 2014-04-16
US20220370567A1 (en) 2022-11-24
JP2019077693A (ja) 2019-05-23
KR102014469B1 (ko) 2019-08-26
RS59107B1 (sr) 2019-09-30
US20140329748A1 (en) 2014-11-06
HRP20240420T1 (hr) 2024-06-21
AU2012293647A1 (en) 2014-02-27
AU2018203222B2 (en) 2020-03-12
EP3646881A1 (en) 2020-05-06
MX381278B (es) 2025-03-12
HRP20191437T1 (hr) 2019-11-15
HUE027674T2 (en) 2016-11-28
JP6500050B2 (ja) 2019-04-10
MX2020010991A (es) 2020-11-09
ES2977682T3 (es) 2024-08-28
JP2014522871A (ja) 2014-09-08
BR122020001644B1 (pt) 2022-08-02
DK2741763T3 (da) 2016-02-15
EP4306174A3 (en) 2024-04-10
RU2739037C3 (ru) 2021-09-08
FI4005588T3 (fi) 2024-05-15
JO3092B1 (ar) 2017-03-15
ES2562648T3 (es) 2016-03-07
RS54561B1 (sr) 2016-06-30
SI2821080T1 (sl) 2019-01-31
US20180028620A1 (en) 2018-02-01
TR201900071T4 (tr) 2019-01-21
RU2739037C2 (ru) 2020-12-21
DK4005588T5 (da) 2024-08-05
DK3646881T3 (da) 2021-07-26
US10624953B2 (en) 2020-04-21
JP6718951B2 (ja) 2020-07-08
AU2016273925B2 (en) 2018-03-15
TWI555530B (zh) 2016-11-01
HRP20190023T1 (hr) 2019-02-22
RS61843B1 (sr) 2021-06-30
HRP20181639T1 (hr) 2018-12-14
EP2741763B1 (en) 2015-11-18
MX348981B (es) 2017-07-06
ES2950911T3 (es) 2023-10-16
TW201716082A (zh) 2017-05-16
NZ620369A (en) 2015-12-24
KR20190100449A (ko) 2019-08-28
IL300380A (en) 2023-04-01
DK3566712T3 (da) 2021-04-19
TWI657822B (zh) 2019-05-01
RU2017106756A (ru) 2019-01-23
CY1117214T1 (el) 2017-04-05
DK3395357T3 (da) 2019-08-19
ES2742163T3 (es) 2020-02-13
AU2018203222A1 (en) 2018-05-24
LT4005588T (lt) 2024-03-25
SI3195875T1 (sl) 2018-11-30
EP3646881B1 (en) 2021-04-28
ES2884947T3 (es) 2021-12-13
EP3395357B1 (en) 2019-05-15
IL230696B1 (en) 2023-03-01
KR20230024442A (ko) 2023-02-20
FI3756681T3 (fi) 2023-07-28
JP7309660B2 (ja) 2023-07-18
KR20210143934A (ko) 2021-11-29
PT4005588T (pt) 2024-04-24
US11291708B2 (en) 2022-04-05
MX2024008825A (es) 2024-07-25
SI2741763T1 (sl) 2016-02-29

Similar Documents

Publication Publication Date Title
HRP20190023T1 (hr) Pripravak za kontroliranu stimulaciju jajnika
IL258934B (en) A method of controlling fuel composition
EP2711011A4 (en) COMPOSITION CONTAINING PANAXADIOL
PT3566712T (pt) Composição para estimulação controlada do ovário
IL213610A0 (en) Composition for treating dermatological conditions
GB201101778D0 (en) Composition
GB201100037D0 (en) Composition
GB201102177D0 (en) Composition